Insomnia in patients with chronic obstructive pulmonary disease: impact on prognosis and treatment approaches

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Acute insomnia (synonym: sleep loss) is a sleep disorder characterized by impaired initiation and/or maintenance of sleep by itself, the development of excessive daytime sleepiness syndrome, loss of daytime activity stimuli. It’s duration is limited to a period ranging from 1–2 weeks to 3 months. Despite existing options for pharmacological and non-pharmacological treatment, acute insomnia in patients with chronic obstructive pulmonary disease remains a serious clinical problem. Current review analyzes data from systematic meta-analyses and randomized clinical trials that expand our understanding of the mechanisms underlying acute insomnia development, as well as the data of new risk-modifying strategies and effective treatment for sleep disorders in patients with chronic obstructive pulmonary disease in real clinical practice.

Full Text

Restricted Access

About the authors

Sergey L. Babak

Russian University of Medicine of the Ministry of Healthcare of Russia

Author for correspondence.
Email: sergbabak@mail.ru
ORCID iD: 0000-0002-6571-1220
SPIN-code: 5213-3620

MD, Dr. Sci. (Medicine), associate professor, professor of the Department of phthisiology and pulmonology of N.A. Semashko Scientific Research Institute of Clinical Medicine

Russian Federation, Moscow

Marina V. Gorbunova

Russian University of Medicine of the Ministry of Healthcare of Russia

Email: mgorb@mail.ru
ORCID iD: 0000-0002-2039-0072

MD, Dr. Sci. (Medicine), associate professor of the Department of phthisiology and pulmonology of N.A. Semashko Scientific Research Institute of Clinical Medicine

Russian Federation, Moscow

Andrey G. Malyavin

Russian University of Medicine of the Ministry of Healthcare of Russia

Email: maliavin@mail.ru
ORCID iD: 0000-0002-6128-5914
SPIN-code: 8264-5394

MD, Dr. Sci. (Medicine), professor, professor of the Department of phthisiology and pulmonology of N.A. Semashko Scientific Research Institute of Clinical Medicine, secretary general of the Russian Scientific Medical Society of Internal Medicine, chief external expert-pulmonologist of the Ministry of Healthcare of Russia for Central Federal District, pulmonologist

Russian Federation, Moscow

References

  1. Hale L, Troxel W, Buysse DJ. Sleep health: An opportunity for public health to address health equity. Annu Rev Public Health. 2020;41:81–99. PMID: 31900098. PMCID: PMC7944938. https://doi.org/10.1146/annurev-publhealth-040119-094412
  2. Sateia MJ. International classification of sleep disorders-third edition: Highlights and modifications. Chest. 2014;146(5):1387–94. PMID: 25367475. https://doi.org/10.1378/chest.14-0970
  3. Momin RR, Aslam SP, Ketvertis K. Short-term insomnia. 2025. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 32119403.
  4. Gauld C, Lopez R, Geoffroy PA, Morin CM, Guichard K, Giroux E et al. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration. Sleep Med Rev. 2021;58:101439. PMID: 33596531. https://doi.org/10.1016/j.smrv.2021.101439
  5. Ban WH, Joo H, Lim JU, Kang HH, Moon HS, Lee SH. The relationship between sleep disturbance and health status in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2049–55. PMID: 29988722. PMCID: PMC6029673. https://doi.org/10.2147/COPD.S167678
  6. Gao Q, Zhu H. Investigating the risk factors for the coexistence of insomnia and its exacerbation in AECOPD. Respir Med. 2025;238:107987. PMID: 39921070. https://doi.org/10.1016/j.rmed.2025.107987
  7. San L, Arranz B. The night and day challenge of sleep disorders and insomnia: A narrative review. Actas Esp Psiquiatr. 2024;52(1):45–56. PMID: 38454895. PMCID: PMC10926017.
  8. Van Someren EJW. Brain mechanisms of insomnia: New perspectives on causes and consequences. Physiol Rev. 2021;101(3):995–1046. PMID: 32790576. https://doi.org/10.1152/physrev.00046.2019
  9. Espie CA. What is insomnia? In: The Clinician’s Guide to Cognitive and Behavioural Therapeutics (CBTx) for Insomnia: A scientist-practitioner approach. Cambridge University Press. 2025:35–56. https://doi.org/10.1017/9781108989480
  10. Palagini L, Geoffroy PA, Gehrman PR, Miniati M, Gemignani A, Riemann D. Potential genetic and epigenetic mechanisms in insomnia: A systematic review. J Sleep Res. 2023;32(6):e13868. PMID: 36918298. https://doi.org/10.1111/jsr.13868
  11. Leerssen J, Lakbila-Kamal O, Dekkers LMS, Ikelaar SLC, Albers ACW, Blanken TF et al. Treating insomnia with high risk of depression using therapist-guided digital cognitive, behavioral, and circadian rhythm support interventions to prevent worsening of depressive symptoms: A randomized controlled trial. Psychother Psychosom. 2022;91(3):168–79. PMID: 34872087. https://doi.org/10.1159/000520282
  12. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–53. PMID: 3332317.
  13. Riemann D, Dressle RJ, Benz F, Spiegelhalder K, Johann AF, Nissen C et al. Chronic insomnia, REM sleep instability and emotional dysregulation: A pathway to anxiety and depression? J Sleep Res. 2025;34(2):e14252. PMID: 38811745. PMCID: PMC11911052. https://doi.org/10.1111/jsr.14252
  14. Reesen JE, van de Kamer FM, van Keeken AE, Ikelaar SLC, van Oppen P, Batelaan N et al. Applying therapist-guided digital cognitive behavioral therapy for insomnia in psychiatry: A mixed-methods process evaluation. BMC Psychiatry. 2025;25(1):428. PMID: 40296081. PMCID: PMC12039299. https://doi.org/10.1186/s12888-025-06824-1
  15. Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012;35(3):369–75. PMID: 22379243. PMCID: PMC3274338. https://doi.org/10.5665/sleep.1698
  16. Kato S, Harada S, Iida M, Kuwabara K, Sugiyama D, Takeuchi A et al. Accumulated unhealthy behaviours and insomnia in Japanese dwellers with and without cardiovascular risk factors: A cross-sectional study. BMJ Open. 2022;12(4):e052787. PMID: 35428620. PMCID: PMC9014032. https://doi.org/10.1136/bmjopen-2021-052787
  17. Lawson Y, Wilding GE, El-Solh AA. Insomnia and risk of mortality in older adults. J Sleep Res. 2024;33(6):e14229. PMID: 38685752. https://doi.org/10.1111/jsr.14229
  18. Nakazaki C, Noda A, Koike Y, Yamada S, Murohara T, Ozaki N. Association of insomnia and short sleep duration with atherosclerosis risk in the elderly. Am J Hypertens. 2012;25(11):1149–55. PMID: 22854638. https://doi.org/10.1038/ajh.2012.107
  19. Ruiz-Burneo L, Merino-Rivera JA, Bernabe-Ortiz A. Type 2 diabetes mellitus and sleep characteristics: A population-based study in Tumbes, Peru. Rev Peru Med Exp Salud Publica. 2022;39(1):55–64. PMID: 35766740. PMCID: PMC11397782. https://doi.org/10.17843/rpmesp.2022.391.10755
  20. Brownlow JA, Miller KE, Gehrman PR. Insomnia and cognitive performance. Sleep Med Clin. 2020;15(1):71–76. PMID: 32005351. PMCID: PMC7000136. https://doi.org/10.1016/j.jsmc.2019.10.002
  21. Yu PC, Chung RJ, Huang YC, Huang SH, Wang BL, Chien WC et al. Chronic obstructive pulmonary disease effect of nonapnea sleep disorder on the risk of obesity: A nationwide population-based case-control study. Int J Environ Res Public Health. 2022;19(7):4118. PMID: 35409801. PMCID: PMC8998813. https://doi.org/10.3390/ijerph19074118
  22. Buysse DJ. Insomnia. JAMA. 2013;309(7):706–16. PMID: 23423416. PMCID: PMC3632369. https://doi.org/10.1001/jama.2013.193
  23. Krystal AD, Ashbrook LH, Prather AA. What is insomnia? JAMA. 2021;326(23):2444. PMID: 34932076. https://doi.org/10.1001/jama.2021.19283
  24. Розанов А.В., Бабак С.Л., Скородумова Е.Г. Модифицируемые факторы риска для достижения здорового долголетия: 10 шагов к здоровому образу жизни. М.: АМСМР. 2025; 40 с. [Rozanov AV, Babak SL, Skorodumova EG. Modifiable risk factors for achieving healthy longevity: 10 steps to a healthy lifestyle. Moscow: Association of Medical Risk Modifiers. 2025; 40 pp. (In Russ.)]. ISBN: 978-5-6054228-0-8.
  25. Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CLA et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035. PMID: 38016484. https://doi.org/10.1111/jsr.14035
  26. Simons FE, Simons KJ. Histamine and H1-antihistamines: Celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139–50.e4. PMID: 22035879. https://doi.org/10.1016/j.jaci.2011.09.005
  27. Левин Я.И., Стрыгин К.Н. Донормил в терапии инсомнии. Лечение нервных болезней. 2005;6(2):16. [Levin YaI, Strygin KN. Donormil in the treatment of insomnia. Lechenie nervnykh bolezney = Treatment of Nervous Diseases. 2005;6(2):16 (In Russ.)].
  28. Мельников А.Ю., Лаврик С.Ю., Бикбулатова Л.Ф., Рагинене И.Г., Иванова Я.А., Захаров А.В. Эффективность препарата Реслип (доксиламин) при острой инсомнии: многоцентровое открытое сравнительное рандомизированное исследование. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(4-2):56–59. [Melnikov AYu, Lavrik SYu, Bikbulatova LF, Raginene IG, Ivanova YaA, Zakharov AV. Effectiveness of Reslip (doxylamine) in short-term insomnia: Multicenter comparative randomized study. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4-2):56–59 (In Russ.)]. EDN: ZCDQKN. https://doi.org/10.17116/jnevro20171174256-59
  29. De Crescenzo F, D’Alo GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: A systematic review and network meta-analysis. Lancet. 2022;400(10347):17–84. PMID: 35843245. https://doi.org/10.1016/S0140-6736(22)00878-9
  30. Драпкина О.М., Концевая А.В., Калинина А.М., Авдеев С.Н., Агальцов М.В., Александрова Л.М. с соавт. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):5–232. [Drapkina OM, Kontsevaya AV, Kalinina AM, Avdeev SN, Agaltsov MV, Alexandrova LM et al. 2022 prevention of chronic non-communicable diseases in of the Russian Federation. National guidelines. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2022;21(4):5–232 (In Russ.)]. EDN: DNBVAT. https://doi.org/10.15829/1728-8800-2022-3235

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. Three-stage insomnia model

Download (382KB)
Indexing metadata

Copyright (c) 2025 Bionika Media